Healthy Activity for Pharma and Biotech in Texas, Montreal
October 29, 2012
U.S. and Canadian companies in the Pharmaceuticals and Biotechnology industry landed a healthy amount of venture funding last week. This industry accounted for 30% of the $395 million in total venture capital invested since last Monday, Oct. 22, according to the PitchBook Platform. The deals behind that strong showing for the space included Montreal, Quebec-based Thrasos Therapeutics' $35 million round, and two Texas companies—Mirna Therapeutics and ZS Pharma—that raised $34.5 million and $46 million, respectively.